MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z
  • Ultrasensitive detection of aggregated α-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson’s Disease

    H. Mao, Y. Kuang, P. Xu (guangzhou, China)

  • Ultrasonography Markers in Prodromal Parkinson’s Disease

    S. Secades Garcia, J. Perez, B. La Casa, A. Contreras, F. Grandas (MADRID, Spain)

  • Ultrasound Assessment of Collagen Content in Contracted and Non-contracted Muscle Areas: A Comparative Study

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

  • Ultrasound of Spinal Fluid Dynamics in Headache and Vertigo Patients with Central Sensitization: Novel Biomarker

    R. Bubnov (Kyiv, Ukraine)

  • Uncovering Non-Motor Subtypes in Parkinson’s Disease through Machine Learning

    G. Pinilla-Monsalve, Y. Song, A. Young, A. Hanganu, O. Monchi (Montreal, Canada)

  • Uncovering Patient Perspectives on Parkinson’s Disease to Inform Individualized Care

    A. Di Rocco, M. Armstrong, J. Carter, C. Chadha, K. Olson, L. Simone, L. Jarzylo (New York, USA)

  • Understanding diffusion in extracellular space in synucleinopathy

    J. Estaún-Panzano, S. Nandi, Q. Gresil, C. Mazzocco, ML. Arotcarena, L. Cognet, E. Bezard (Bordeaux, France)

  • Understanding Parkinson’s disease in Spain: genetic and clinical insights

    M. Martín-Bornez, L. Muñoz-Delgado, R. Diaz-Belloso, MT. Periñán, M. Bonilla-Toribio, D. Buiza-Rueda, D. Macías-García, S. Jesús, A. Adarmes-Gómez, E. Ojeda, A. Luque-Ambrosiani, S. García-Díaz, R. Pineda, F. Carrillo, P. Mir, P. Gómez-Garre (Seville, Spain)

  • Understanding Patient and Care Partner Educational Preferences in Atypical Parkinsonism

    M. Ivancic, M. Comeau, R. Mahabir, C. Malburg, J. Shurer, K. Woods, E. Zivin, CY. Lin (Chapel Hill, USA)

  • Understanding Sleep-wake Disturbances in Dementia with Lewy Bodies Using Parametric and Non-parametric Measures in Wrist Actigraphy

    J. Anderson, N. Chiu, J. Pye, R. Grunstein, S. Lewis, E. Matar (Camperdown, Australia)

  • Understanding the earliest phases of Parkinson’s disease (PD) – an expanding opportunity to study ‘at-risk’/early/prodromal PD in the Global Parkinson’s Genetics Program (GP2)

    K. Atterling Brolin, S. Jasaityte, M. Teferra, M. Rezaei, L. Jones, J. Trinh, E. Stafford, M. Makarious, M T. Periñan, L. Lange, S. Waters, A. Martinez Carrasco, M. Tan, H. Iwaki, H. Morris, C. Blauwendraat, A. Singleton, Z. Gan-Or, A. Noyce (Lund, Sweden)

  • Understanding the Neurochemical Basis of STN and GPi-DBS: A Human Microdialysis Study

    M. Ghilardi, R. Martinez, I. Ivo Lebrun, M. Carvalho, A. Auada, M. Brandao, E. Barbosa, E. Fonoff (São Paulo, Brazil)

  • Understanding the neuroprotective mechanism of ilex Paraguariensis (Yerba mate) in a Drosophila melanogaster alpha-synuclein model of Parkinson’s disease

    A. Tschopp, P. Ballestero, G. Decurgez, H. Hauche, T. Eidelman, M. Bordone, N. Muraro, J. Ferrario (CABA, Argentina)

  • Unilateral Deep Brain Stimulation in Parkinson’s Disease: Long-term Efficacy and Bilateral Symptom Progression

    S. Akkus, H. Park, W. Saengphatrachai, J. Jimenez-Shahed, B. Kopell (New York, USA)

  • Unilateral MRgFUS subthalamotomy in Parkinson’s disease: A prospective clinical study

    L. Armengou-Garcia, C. Sanchez-Catasus, I. Aviles Olmos, A. Jimenez-Huete, G. Montoya Murillo, A. Gorospe Osinalde, A. Martin Bastida, L. Gonzalez-Quarante, J. Guridi Legarra, MC. Rodriguez-Oroz (Pamplona, Spain)

  • Unique Presentation of SPG 15 as Juvenile Levodopa Responsive Parkinsonism: A Case Report

    D. Nayar, A. Boddu, T. Virmani (little rock, USA)

  • Unlocking Movement Disorder Specialist Capacity and Mitigating Risk: a Platform Solution for Cost Reduction and Care Optimization in Parkinson’s Disease

    A. Arnold, A. Hare, T. Jansen, M. Sedrak, S. Khandhar, W. Chen, R. Gilron (San Francsico, USA)

  • Unmet Motor and Nonmotor Needs of People with Parkinson’s in the Final Year of Life

    K. Rukavina, M. Al-Agil, K. Poplawska-Domaszewicz, S. Veronese, D. Oliver, K. Ray Chaudhuri (London, United Kingdom)

  • Unraveling Plantar Pressure Dynamics in Parkinson’s Disease with Freezing of Gait: Taking Steps through Its Characters and Predictive Factors

    T. Tiraweerakhajorn, W. Phuenpathom, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

  • Unraveling the Complexity of Neurodegenerative Disorders: A Case Report of PKAN Suspected in a 24-Year-Old Patient with Severe Dystonia

    L. Kenjaeva, B. Mukhammedaminov, R. Abdukakhkhorova (Tashkent, Uzbekistan)

  • Unraveling the Role of Short Tandem Repeats in Parkinson’s disease, Essential tremor, and Amyotrophic lateral sclerosis: A Large Chinese Cohort Study

    Y. Zhao, Z. Liu, H. Pan, Q. Sun, J. Wang, J. Guo, B. Tang (Changsha, China)

  • Unsupervised Learning Approach for Pathology-Based Subtyping and Staging Multiple System Atrophy

    H. Sekiya, D. Ono, D. Dickson (Jacksonville, USA)

  • Untangling Bidirectional Influences of Somatic and Internalizing Symptoms among People with Parkinson’s Disease: A Retrospective Cohort Study

    E. Demarco, D. Subramaniam, J. Scherrer, G. Grossberg, L. Hinyard (St. Louis, USA)

  • Untargeted Serum Metabolomics Identifies Glycine-Serine Metabolism Disruption as Biochemical Bignature in Parkinson’s Disease

    A. Imarisio, C. Marino, M. Avenali, G. Buongarzone, M. Picascia, T. Nuzzo, C. Gasparri, F. Errico, M. Grimaldi, MC. Monti, A. Filosa, M. Rondanelli, C. Pacchetti, AM. D'Ursi, A. Usiello, EM. Valente (Pavia, Italy)

  • Unusual Causes of Reversible Myoclonus: A Video Based Case Series

    S. Jha (Kolkata, India)

  • Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

    A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

  • Unveiling the Link: Insulin’s Novel Role in Modulating α-Synuclein Accumulation in Parkinson’s Disease

    Y. Wu (München, Germany)

  • Unveiling the Long-term Impact of Unilateral Vim DBS in Essential Tremor

    F. Sarmento, V. Srikar Lavu, C. de Hemptinne, A. Ramirez-Zamora (Gainesville, USA)

  • Unwinding Anxiety: Feasibility and Effectiveness of App-Based Mindfulness Training for People with Anxiety and Parkinson’s Disease: A Pilot Study

    E. Weisbach, A. Demarco, J. Molino, A. Seritan, P. Prakash (Providence, USA)

  • Use of Machine Learning for Identification of Parkinson’s Disease and Mild Cognitive Impairment through Neuroimaging and Biofluid Biomarkers: A Study from the PPMI Cohort

    A-G. Dennis, A. Strafella (Toronto, Canada)

  • Use of Personalized Musical Cues to Optimize Walking in People With (and Without) Parkinson Disease

    G. Earhart, L. Tueth, A. Haussler, K. Rawson, E. Harrison (Saint Louis, USA)

  • Use of social media and health information technology among caregivers of Alzheimer’s disease and other neurological conditions: Secondary analysis of the 2022 Health Information National Trend (HINTS) Survey

    M. Arbabi Kalati (Hinsdale, USA)

  • Using Algorithm Guided Programming to Treat Parkinson’s Disease Patients Implanted with Deep Brain Stimulation

    C. Luca, Y. Lin, K. Su, J. Jagid, V. Torres, R. Shivacharan, L. Moore (Miami, USA)

  • Using LEAD-DBS to Identify the Optimal DBS Electrode in the Abbott Infinity System

    J. Karl, S. Dong, C. Taylor, N. Shetty, J. Rosenow, M. Nolt, L. Verhagen Metman (Chicago, USA)

  • Utility of Instrumented Timed Up and Go Test to Estimate Disease Severity in Huntington Disease.

    D. Wani, M. Lin, C. Macpherson, T. Ravikumar, M. Campbell, L. Muratori, N. Fritz, L. Quinn (New York, USA)

  • Utility of Serum α-synuclein Seed Amplification Assay as a Parkinson’s Disease Biomarker

    S. Mosovsky, A. Okuzumi, C. Adler, T. Beach, T. Foroud, G. Serrano, J. Eberling, L. Oliveira, T. Hatano, N. Hattori, B. Mollenhauer, L. Chahine (Pittsburgh, USA)

  • Utility of using long-read whole genome sequencing to solve exome negative early-onset and familial Parkinson’s disease: a series of 106 individuals

    G. Cogan, K. Bilingsley, K. Daida, C. Tesson, T. Courtin, M. Ferrien, A. Singleton, S. Lesage, C. Blauwendraat, A. Brice (Paris, France)

  • Utility of Whole Exome Sequencing in movement disorders potentially related to Mitochondrial cytopathies

    D. Dhar, V. Holla, P. Phulpagar, R. Yadav, N. Netravathi, B. Muthusamy, P. Pal (Bangalore, India)

  • Utilization of Skin Punch Biopsy for the Diagnosis of Alpha-synucleinopathy in Clinical Practice

    C. Gummerson, S. Tinaz, V. Santini, A. Zubair (New Haven, USA)

  • Utilizing a global network to study environmental factors relating to Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)

    K. Atterling Brolin, L. Jones, B. Fiske, S. Jasaityte, H. Morris, A. Noyce (Lund, Sweden)

  • Utilizing a tablet-based digital drawing to discriminate Parkinson’s disease from essential tremor

    Z. Liu, SN. Lin, XM. Wang, Z. Wang, F. Zhang, Y. Ling, K. Ren, ZL. Chen, T. Feng (Beijing, China)

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley